SCHEMBL28057767

SCHEMBL28057767

C#Cc1cccc(-c2ccc(C(N)=O)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 6/20 0.49
MKNK2 Q9HBH9 5/20 0.49
DHODH Q02127 3/20 0.45
AOC3 Q16853 2/20 0.45
MYC P01106 1/20 0.44
ERN1 O75460 2/20 0.44
CHEK2 O96017 2/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28057748 0.88 ERN1 (0.49) DHODHERN1CA12CA1CA2
SCHEMBL27716780 0.85 TRIM24 (0.54) MKNK1MKNK2
SCHEMBL31371753 0.82 CA12 (0.50) MKNK1MKNK2MYCERN1CA12
SCHEMBL1568517 0.80 PARP1 (0.53) CA12CA1CA2CA9CA14
SCHEMBL22367342 0.80 MKNK1 (0.64) MKNK1MKNK2DHODHAOC3ERN1
SCHEMBL23380281 0.80 EGFR (0.55) ERN1CA12CA1CA2CA9
SCHEMBL2589651 0.78 ERN1 (0.60) MKNK1MKNK2DHODHERN1
SCHEMBL3843982 0.78 CA12 (0.42) CA12CA1CA2CA9CA14
SCHEMBL3841296 0.78 CA12 (0.48) CA12CA1CA2CA9CA14
SCHEMBL11352929 0.77 TAAR1 (0.52) CA12CA1CA2CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105431436-B Pyrrolo [2,3-D ] pyrimidine derivatives, processes for their preparation and their use as kinase inhibitors 内尔维阿诺医学科学有限公司 2017-11-28 CN disclosed
CN-105431436-A Pyrrolo [2,3-D ] pyrimidine derivatives, processes for their preparation and their use as kinase inhibitors NERVIANO MEDICAL SCIENCES SRL 2016-03-23 CN disclosed